×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ELDN – eledon pharmaceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ELDN
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/2
03:41 pm
eldn
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Low
Report
Eledon Pharmaceuticals (NASDAQ:ELDN) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
12/1
07:13 am
eldn
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference [Yahoo! Finance]
12/1
07:00 am
eldn
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
Medium
Report
Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference
11/18
04:05 pm
eldn
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
Medium
Report
Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine
11/18
09:14 am
eldn
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
Eledon Pharmaceuticals (NASDAQ:ELDN) had its price target lowered by analysts at Guggenheim from $9.00 to $8.00. They now have a "buy" rating on the stock.
11/17
01:19 pm
eldn
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
Low
Report
Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript [Seeking Alpha]
11/14
05:58 pm
eldn
Eledon Pharmaceuticals GAAP EPS of -$0.21 [Seeking Alpha]
High
Report
Eledon Pharmaceuticals GAAP EPS of -$0.21 [Seeking Alpha]
11/14
05:26 pm
eldn
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results [Yahoo! Finance]
Medium
Report
Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/14/2025
05:00 pm
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
-7.0%
eledon pharmaceuticals, inc.
8/14/2025
04:20 pm
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
1.2%
eledon pharmaceuticals, inc.
5/14/2025
04:01 pm
ELDN
eledon pharmaceuticals, inc.
BEAT
Report
2.1%
eledon pharmaceuticals, inc.
Date
Time
Symbol
Headline
Impact
11/24
03:29 pm
eldn
Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: Coastlands Capital LP
Medium
Report
Form SCHEDULE 13G Eledon Pharmaceuticals, Filed by: Coastlands Capital LP
11/14
05:12 pm
eldn
Form 8-K Eledon Pharmaceuticals, For: Nov 14
Medium
Report
Form 8-K Eledon Pharmaceuticals, For: Nov 14
11/14
05:06 pm
eldn
Form 10-Q Eledon Pharmaceuticals, For: Sep 30
Medium
Report
Form 10-Q Eledon Pharmaceuticals, For: Sep 30
11/13
06:05 am
eldn
Form 8-K Eledon Pharmaceuticals, For: Nov 12
High
Report
Form 8-K Eledon Pharmaceuticals, For: Nov 12
11/13
06:05 am
eldn
Form 424B5 Eledon Pharmaceuticals,
High
Report
Form 424B5 Eledon Pharmaceuticals,
11/12
06:06 am
eldn
Form 424B5 Eledon Pharmaceuticals,
Low
Report
Form 424B5 Eledon Pharmaceuticals,
11/7
06:02 am
eldn
Form 8-K Eledon Pharmaceuticals, For: Nov 06
Medium
Report
Form 8-K Eledon Pharmaceuticals, For: Nov 06
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: